Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Clinical Feasibility of the BinaxNOW™ COVID-19/Flu A&B Combo in the Southern Hemisphere

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06928129
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:37.188068+00:00
Published At
2025-04-15T00:00:00+00:00
Record Updated At
2025-04-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Influenza Type A", "Influenza Type B", "COVID-19"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-04-15"
protocolSection.identificationModule.nctId
"NCT06928129"
protocolSection.identificationModule.officialTitle
"Clinical Feasibility of the BinaxNOW\u2122 COVID-19/Flu A\u0026B Combo in the Southern Hemisphere"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Influenza Type A (protocolSection.conditionsModule.conditions)
  • Influenza Type B (protocolSection.conditionsModule.conditions)
  • COVID-19 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.